1211387

Philip R. Clingan — FEI 3026365459

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 20, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Wollongong (Australia)

Additional Details

Clinical Investigator (CI)